Abstract
Animal models are essential for in vivo analysis of Helicobacter-related diseases. Transgenic mice and Mongolian gerbil models have been the corner stone of present research focusing on both bacterial virulence factors and host response to infection. Establishing a reproducible rodent model of persistent Helicobacter pylori infection that resembles the H. pylori-associated gastritis observed in humans was a considerable challenge until Lee et al. (Gastroenterology 112:1386–1397, 1997) successfully adapted a clinical Cag A- and Vac A-expressing strain for the mouse stomach. This so-called SS1 (Sydney) strain has since been extensively used for H. pylori research; other rodent-adapted Helicobacter strains have subsequently been developed and utilized in wild-type and genetically engineered rodent models. These bacteria include both H. pylori and the larger but related species H. felis (originally isolated from cats). In this chapter we focus mainly on these two Helicobacter strains and review the rodent models that have been employed to investigate how Helicobacter species induce gastric inflammation and disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lee A, O’Rourke J, De Ungria MC et al (1997) A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112:1386–1397, PMID: 9098027
Mohammadi M, Redline R, Nedrud J, Czinn S (1996) Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect Immun 64:238–245, PMID: 8557346
Thompson LJ, Danon SJ, Wilson JE et al (2004) Chronic Helicobacter pylori infection with Sydney strain 1 and a newly identified mouse-adapted strain (Sydney strain 2000) in C57BL/6 and BALB/c mice. Infect Immun 72:4668–4679, PMID: 15271928
Sakagami T, Dixon M, O’Rourke J et al (1996) Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut 39:639–648, PMID: 9026476
Boivin GP, Washington K, Yang K et al (2003) Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124:762–777, PMID: 12612914
Rogers AB, Houghton J (2009) Helicobacter-based mouse models of digestive system carcinogenesis. Methods Mol Biol 511:267–295, PMID: 19347301
Wang TC, Goldenring JR, Dangler C et al (1998) Mice lacking secretory phospholipase A2 show altered apoptosis and differentiation with Helicobacter felis infection. Gastroenterology 114:675–689, PMID: 9516388
Dixon MF, Genta RM, Yardley JH, Correa P (1996) Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20:1161–1181, PMID: 8827022
Cai X, Carlson J, Stoicov C et al (2005) Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice. Gastroenterology 128:1937–1952, PMID: 15940628
Correa P, Haenszel W, Cuello C, Tannenbaum S, Archer M (1975) A model for gastric cancer epidemiology. Lancet 2:58–60, PMID: 49653
Kim DH, Kim SW, Song YJ et al (2003) Long-term evaluation of mice model infected with Helicobacter pylori: focus on gastric pathology including gastric cancer. Aliment Pharmacol Ther 18(Suppl 1):14–23, PMID: 12925137
Houghton J, Stoicov C, Nomura S, Rogers AB et al (2004) Gastric cancer originating from bone marrow-derived cells. Science 306:1568–1571, PMID: 15567866
Enno A, O’Rourke JL, Howlett CR et al (1995) MALToma-like lesions in the murine gastric mucosa after long-term infection with Helicobacter felis A mouse model of Helicobacter pylori-induced gastric lymphoma. Am J Pathol 147:217–222, PMID: 7604881
Enno A, O’Rourke J, Braye S, Howlett R, Lee A (1998) Antigen-dependent progression of mucosa-associated lymphoid tissue (MALT)-type lymphoma in the stomach Effects of antimicrobial therapy on gastric MALT lymphoma in mice. Am J Pathol 52:1625–1632, PMID: 9626066
Wang X, Willén R, Svensson M, Ljungh A, Wadström T (2003) Two-year follow-up of Helicobacter pylori infection in C57BL/6 and Balb/cA mice. APMIS 111:514–522, PMID: 12780527
Takata T, El-Omar E, Camorlinga M et al (2002) Helicobacter pylori does not require Lewis X or Lewis Y expression to colonize C3H/HeJ mice. Infect Immun 70:3073–3079, PMID: 12011000
Mähler M, Janke C, Wagner S, Hedrich HJ (2002) Differential susceptibility of inbred mouse strains to Helicobacter pylori infection. Scand J Gastroenterol 37:267–278, PMID: 11916188
Wang TC, Dangler CA, Chen D et al (2000) Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 118:36–47, PMID: 10611152
Fox JG, Wang TC, Rogers AB et al (2003) Host and microbial constituents influence Helicobacter pylori-induced cancer in a murine model of hypergastrinemia. Gastroenterology 124:1879–1890, PMID: 12806621
Fox JG, Rogers AB, Ihrig M et al (2003) Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 63:942–950, PMID: 12615707
Fox JG, Beck P, Dangler CA, Whary MT, Wang TC et al (2000) Concurrent enteric helminth infection modulates inflammation and gastric immune responses and reduces helicobacter-induced gastric atrophy. Nat Med 6:536–542, PMID: 10802709
Whary MT, Fox JG (2004) Th1-mediated pathology in mouse models of human disease is ameliorated by concurrent Th2 responses to parasite antigens. Curr Top Med Chem 4:531–538, PMID: 14965304
Stoicov C, Whary M, Rogers AB et al (2004) Coinfection modulates inflammatory responses and clinical outcome of Helicobacter felis and Toxoplasma gondii infections. J Immunol 173:3329–3336, PMID: 15322196
Lofgren JL, Whary MT, Ge Z et al (2011) Lack of commensal flora in H. pylori-infected INS-GAS mice reduces gastritis and delays intraepithelial neoplasia. Gastroenterology 140:210–220, PMID: 20950613
Hasegawa S, Nishikawa S, Miura T et al (2004) Tumor necrosis factor-alpha is required for gastritis induced by Helicobacter felis infection in mice. Microb Pathog 37:119–124, PMID: 15351034
Sawai N, Kita M, Kodama T et al (1999) Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun 67:279–285, PMID: 9864227
Yamamoto T, Kita M, Ohno T et al (2004) Role of tumor necrosis factor-alpha and interferon-gamma in Helicobacter pylori infection. Microbiol Immunol 48:647–654, PMID: 15383700
El-Omar EM, Carrington M, Chow WH et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398–402, PMID: 10746728
Tu S, Bhagat G, Cui G, Takaishi S et al (2008) Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell 14:408–419, PMID: 18977329
Berg DJ, Lynch NA, Lynch RG, Lauricella DM (1998) Rapid development of severe hyperplastic gastritis with gastric epithelial dedifferentiation in Helicobacter felis-infected IL-10 (−/−) mice. Am J Pathol 152:1377–1386, PMID: 9588906
Houghton JM, Bloch LM, Goldstein M, Von Hagen S, Korah RM (2000) In vivo disruption of the fas pathway abrogates gastric growth alterations secondary to Helicobacter infection. J Infect Dis 182:856–864, PMID: 10950781
Cai X, Stoicov C, Li H, Carlson J, Whary M, Fox JG, Houghton J (2005) Overcoming Fas-mediated apoptosis accelerates Helicobacter-induced gastric cancer in mice. Cancer Res 65:10912–10920, PMID: 16322238
Chu IM, Hengst L, Slingerland JM (2008) The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 8:253–267, PMID: 18354415
Shirin H, Sordillo EM, Kolevska TK et al (2000) Chronic Helicobacter pylori infection induces an apoptosis-resistant phenotype associated with decreased expression of p27 (kip1). Infect Immun 68:5321–5328, PMID: 10948161
Fero ML, Randel E, Gurley KE, Roberts JM, Kemp CJ (1998) The murine gene p27 Kip1 is haplo-insufficient for tumor supression. Nature 396:177–180, PMID: 9823898
Kuzushita N, Rogers AB, Monti NA et al (2005) p27 kip1 deficiency confers susceptibility to gastric carcinogenesis in Helicobacter pylori-infected mice. Gastroenterology 129:1544–1556, PMID: 16285954
Ohnishi N, Yuasa H, Tanaka S et al (2008) Transgenic expression of Helicobacter pylori Cag A induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 105:1003–1008, PMID: 18192401
Hirayama F, Takagi S, Iwao E et al (1999) Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils. J Gastroenterol 34:450–454, PMID: 10452676
Ikeno T, Ota H, Sugiyama A, Ishida K, Katsuyama T, Genta RM, Kawasaki S (1999) Helicobacter pylori-induced chronic active gastritis, intestinal metaplasia, and gastric ulcer in Mongolian gerbils. Am J Pathol 154(3):951–960, PMID: 10079274
Zheng Q, Chen XY, Shi Y et al (2004) Development of gastric adenocarcinoma in Mongolian gerbils after long-term infection with Helicobacter pylori. J Gastroenterol Hepatol 19:1192–1198, PMID: 15377299
Yoshizawa N, Takenaka Y, Yamaguchi H et al (2007) Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Lab Invest 87:1265–1276, PMID: 18004396
Watanabe T, Tada M, Nagai H et al (1998) Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 115:642–648, PMID: 9721161
Honda S, Fujioka T, Tokieda M et al (1998) Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 58:4255–4259, PMID: 9766647
Tatematsu M, Tsukamoto T, Mizoshita T (2005) Role of Helicobacter pylori in gastric carcinogenesis: the origin of gastric cancers and heterotopic proliferative glands in Mongolian gerbils. Helicobacter 10:97–106, PMID: 15810939
Peek RM Jr, Wirth HP, Moss SF et al (2000) Helicobacter pylori alters gastric epithelial cell cycle events and gastrin secretion in Mongolian gerbils. Gastroenterology 118:48–59, PMID: 10611153
Israel DA, Salama N, Arnold CN, Moss SF et al (2001) Helicobacter pylori strain-specific differences in genetic ontent, identified by microarray, influence host inflammatory responses. J Clin Invest 107:611–620, PMID: 11238562
Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52:6735–6740, PMID: 1458460
Wroblewski LE, Peek RM Jr, Wilson KT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23:713–739, PMID: 20930071
Sugiyama A, Maruta F, Ikeno T et al (1998) Helicobacter pylori infection enhances N-methyl-N-nitrosourea-induced stomach carcinogenesis in the Mongolian gerbil. Cancer Res 58:2067–2069, PMID: 9605743
Tokieda M, Honda S, Fujioka T et al (1999) Effect of Helicobacter pylori infection on the N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in mongolian gerbils. Carcinogenesis 20:1261–1266, PMID: 10383899
Yamachika T, Nakanishi H, Inada K et al (1998) N-methyl-N-nitrosoureaconcentration-dependent, rather than total intake-dependent, induction of adenocarcinomas in the glandular stomach of BALB/c mice. Jpn J Cancer Res 89:385–391, PMID: 9617343
Han SU, Kim YB, Joo HJ et al (2002) Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J Gastroenterol Hepatol 17:253–261, PMID: 11982694
Fuccio L, Zagari RM, Eusebi LH et al (2009) Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 151:121–128, PMID: 19620164
Lee CW, Rickman B, Rogers AB et al (2008) Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res 68:3540–3548, PMID: 18441088
Romero-Gallo J, Harris EJ, Krishna U et al (2008) Effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest 88:328–336, PMID: 18180700
Zullo A, Hassan C, Cristofari F et al (2010) Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol 8:105–110, PMID: 19631287
Lee CW, Rickman B, Rogers AB et al (2009) Combination of sulindac and antimicrobial eradication of Helicobacter pylori prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. Cancer Res 69:8166–8174, PMID: 19826057
DeLyria ES, Redline RW, Blanchard TG (2009) Vaccination of mice against H. pylori induces a strong Th-17 response and immunity that is neutrophil dependent. Gastroenterology 247–256, PMID: 18948106
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Zhang, S., Moss, S.F. (2012). Rodent Models of Helicobacter Infection, Inflammation, and Disease. In: Houghton, J. (eds) Helicobacter Species. Methods in Molecular Biology, vol 921. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-005-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-62703-005-2_12
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-004-5
Online ISBN: 978-1-62703-005-2
eBook Packages: Springer Protocols